ww

w.m

ed

ica

lda

rpa

n.c

om

Dr. Reddy’s Laboratories enters Nutrition Segmentwith Celevida in India

Hyderabad:- Dr. Reddy’s Laboratories Ltd. Mob:-09058458612, 09307668480, 09305955262, 09761760618announced the entry into the nutrition segment with the launch ofits diabetes nutrition drink ‘Celevida’ in India. It’s a first-of-its-kindunder Dr. Reddy’s nutrition portfolio and clinically proven to helpmanage blood glucose levels among Indian patients. The brand‘Celevida’ is derived from two words ‘Celebration’ and ‘Vida’*,which means ‘Celebrate Life’. It is available in two flavors – Kesar

Elachi and Chocolate, which are taste tested with 300+ diabetics and prediabetics1 . M VRamana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr. Reddy’sLaboratories said, “We are pleased to mark our foray into the nutrition segment with Celevida,which will address unmet nutrition needs of the patients in India. Through this nutrition drink, wecontinue to work towards making a positive impact on people’s health and quality of life.” Dr.Reddy’s Celevida is formulated to have high protein (28-30%), high fiber (12-18%) and slowlydigested carbohydrates, which will support in managing the postprandial blood glucose responseand satiety2 . The product contains high amount of plant protein that comes from Soy, Ragi andGram flours. The product has 20 vitamins and minerals, and ingredient such as Folate, Iron,Magnesium, Pantothenic acid, Riboflavin, Vitamin B12, Vitamin B6 and Vitamin C that would fur-ther support in managing tiredness and fatigue3 . Diabetes is a growing challenge in India with alarge diabetic (around 73 million) and pre-diabetes population (around 80 million people) and weare estimated to have world’s largest diabetes population by 20354 . What is contributing to therise of diabetes in the growing population is the changing habits of diet and a sedentary lifestyle.The Indian Council of Medical Research has recommended that, the daily diet of an adult shouldcontain at least 60g of protein and 40g of dietary fibre (based on a 2000 Kcal diet)5.

Sun Pharma Reports Q2FY20 ResultsQ2 Gross Sales at Rs. 7,949 crores up 16% YoY Q2 NetProfit at Rs. 1,064 crores up 12.6% YoY Mumbai, November07, 2019: Sun Pharmaceutical Industries Ltd. Mob:-09958124414, 09412480312 reported financials for the sec-ond quarter & first half ending September 30th, 2019.Highlights of Q2FY20 consolidated financials l Sales /Income from operations at Rs. 7,949 crores, a growth of 16%over same quarter last year. l India sales at Rs. 2,515 crores,growth of 35% over Q2 last year. l US finished dosage salesat US$ 339 million, flat over Q2 last year. l Emerging Markets

sales at US$ 201 million, up by 3% Q2 last year. l Rest of World sales at US$161 million, growth of 49% over Q2 last year. l R&D investments at Rs. 488crores (6.1% of sales) compared to Rs. 452 crores (6.6% of sales) for Q2FY19.l EBITDA at Rs. 1,616 crores up by 12% over Q2 last year, with resulting EBIT-DA margin of 20.3%. l Net profit for quarter at Rs. 1,064 crores, with resultingnet profit margin at 13.4%. Adjusted for the exceptional item of Rs. 1,214 croresfor Q2 last year, net profit growth was 12.6%. Highlights of H1FY20 consolidat-ed financials l Sales / Income from operations at Rs. 16,208 crores, growth of16% over same period last year. l India sales at Rs. 4,828 crores, up by 20%over H1 last year. l US finished dosage sales at US$ 763 million up by 6% overH1 last year. l Emerging Markets sales at US$ 394 million up by 1% over H1last year. l Rest of World sales at US$ 328 million, growth of 52% over H1 lastyear. l EBITDA at Rs. 3,496 crores up by 18% over H1 last year, with resultingEBITDA margin of 21.6%. l Net profit for H1FY20 at Rs. 2,452 crores, withresulting net profit margin at 15.1%. Adjusted for the exceptional item of Rs.1,214 crores for H1 last year, net profit growth was 22.5%. These results weretaken on record by the Board of Directors at a meeting held in Mumbai today.Dilip Shanghvi, Managing Director of the Company said, “Our Q2 and H1 per-formance demonstrates sustained growth momentum and is in-line with our full-year guidance. We continue to focus on cost savings and efficiency improve-ment to align our generic business with the changing industry dynamics.Simultaneously, we continue to progress on building our global specialty busi-ness. In the US, we recently launched Cequa while Ilumya continues to gaintraction. The recently released long-term follow-up clinical data for Ilumyademonstrates sustained response for patients over four-year period with verygood safety profile. We are excited about the long term prospects of Ilumya."

Aurobindo Pharma Receives USFDA Approval ForGuaifenesin Extended-Release Tablets (OTC)

Aurobindo Pharma Limited Ph.:- +91 (40) 66725000 is pleased toannounce that the company has received final approval from the US Food& Drug Administration (USFDA) to manufacture Guaifenesin extended-release tablets, 600 mg and 1200 mg (OTC). Aurobindo’s Guaifenesinextended-release tablets are the AB rated generic equivalent of RBHealth (US) LLC’s Mucinex® tablets. The product is expected to launch

in Q4FY20. Guaifenesin extended-release tablets helps to loosen phlegm (mucus), and thinbronchial secretions to rid the bronchial passageways of bothersome mucus and make coughsmore productive. The approved product has an estimated market size of US$ 301 million for thetwelve months ending July 2019, according to IRI database. This is the 10 th ANDA (including 1tentative approval) approved out of Unit X formulation facility in Naidupet, Andhra Pradesh, Indiaused for manufacturing oral products. Aurobindo now has a total of 419 ANDA approvals (392Final approvals including 21 from Aurolife Pharma LLC and 27 tentative approvals) from USFDA.

USFDA Finds several Violations In Aurobindo SterileInjections Unit

NEW DELHI:- The US Food and Drug Administration has observed several violationsand shortcomings in Aurobindo Pharma’s sterile injections facility in Pashamylaram,Hyderabad, in yet another setback for the firm. FDA investigators have observed vio-lations in sterilisation process to prevent microbial contamination and shortcomings infacility management procedures along with major protocol lapses in its sterile unit.The same unit had come under the FDA radar in March 2018. The inspection at UnitIV from November 4-13 found “procedures designed to prevent microbial contamina-tion of drug products purporting to be sterile did not include adequate validation of theaseptic and sterilisation process .. ,” said the Form 483 ‘inspectional observation’report. EThas seen a copy of the Form 483 issued to Aurobindo Pharma. It said theunit does not follow established test procedures, and that senior company managersc o n f i r m e d to investiga-tors that cleaning andsanitising is not done peri-o d i c a l l y . Form 483 list-ed 14 observations.Specifically, it foundrecords of inspections ofautomat ic, m e c h a n i c a lor electron- ic equipment,i n c l u d i n g computers orrelated sys- tem were notmaintained. “The qualitycontrol unit lacks authori-ty to review p r o d u c t i o nrecords to assure thatno errors have occurred and fully investigate errors that have,” it said. ET first report-ed about the FDA inspections at the plant on November 5. Aurobindo did not respondto ET’s emailed queries as of press time Friday. FDA investigators also found that thelaboratory does not perform enough quality control check to ensure analysts are per-forming tests adequately on a consistent basis. “Laboratory records are deficient inthat they do not include the initials and signatures of the person performing the testsand dates tests were performed,” the report said. It also noted that employees are notgiven training in particular operations they perform, and observed lapses in the leach-ability studies and biocompatibility studies. The unit IV is Aurobindo’s key injectableformulations plant, accounting for 9-10% of the firm’s US sales and 50-60% of its totalinjectable sales in FY19. The plant also accounted for 8-9% of the company’s overalloperating profit during the period. Aurobindo will now have to respond to FDA withcorrective measures to get the plant cleared within a stipulated time.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj esa gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsaA

Indian Fharma Fair Pune (Maharashtra) 6 th & 7 th Dec-2019Free Entry For All Visitors

Vedshiv Business Media Pvt Ltd is going to organise Indian Fharma Fair on 6th &amp; 7 th Dec-2019 at Deccan College Ground in Pune ( Maharashtra )This Exhibition will focus to Grow Pharma Business mainly PCD/Franchisee&amp; 3 rd Party Manufacturing in all over Maharashtra. All PharmaProfessionalsare invited to visit this exhibition. Pharma Persons from all overMahrashtra are expected to visit at venue/ Exhibition. This Exhibition isPowered by Sigma Softgel &amp; Formulation and copowered by CascaRemedies Pvt Ltd. This event is done with our Diamond Partner Sarthak Groupof Companies, Platinum Partner Sai Healthcare, Gold Partner Signa MediSolutions (P) Ltd &amp; Silver Partner SB Lifesciences. Supporting Partner

Forgo Pharmaceuticals (P) Ltd and Best Biotech. Printing Partner Graphic Ganga Pvt Ltd. Media PartnerMedical Darpan &amp; The Pharma Chem Monthly. More than 40 Pharma Manufacturing Companies areparticipating in the Exhibition. Following Companies are participating: - Sigma Softgel &amp;Formulation, Casca Remedies, Sarthak Group of Companies, Signa Healthcare, SB Lifesciences, ForgoPharmaceutical (P) Ltd, Best Biotech, Wonder Products, Medicant Nutrients, Vetmed Biotech, ResearchMedicine Pvt Ltd, Fawn Incorporation, Sunvet Healthcare, Iskon Remedies, Bionet India Pvt Ltd, Cu-V-Kar Genetic Medicine, Ethnic Biotech, Syndicate Life Sciences Pvt Ltd, Uni-Pex Pharmaceutical Pvt Ltd,Mestra Pharma Pvt Ltd, Sag Health Science Pvt Ltd, Zoic Life Sciences Pvt Ltd, Matish Healthcare,Puremed Biotech, Devbhoomi Pharmaceuticals, Diksha Ayurveda, V- Care Biotech, Arvincare, QuepreonBiologicals, Liv Well Healthcare, Broad Injectables, Zenacts Pharma Pvt Ltd, Bluebell Pharma, SkinVenture, Nexkem Pharmaceuticals & Janus Biotech (I) Pvt Ltd. For any Query one can Contsct Mr. B.S.

Bhandari (GM) - 9971516888 & Mr. Shivam Sharma (Chief Business Officer) - 9258002828.

dEifu;k¡ ftudh nok lcLVSaMMZ ik;h x;hM/S.Bengal Chemicals & Pharmaceuticals Ltd. Kanpur-208012 (Uttar Pradesh). l M/s Orissa Drugs andChemicals Ltd. Bhubaneswar (Odissa). l M/s Hanuchem Laboralories V.P.O. Solan-173205 (H.P.) l M/sBiogenetic Drugs Pvt.Ltd. Solan-174103 (H.P.) l M/s Park Pharmaceuticals, Solan-174103 (H.P.) l M/sAppasamy Occular Devices (P) Ltd. Solan-173205 (H.P.) l M/s Laboratories Filorga-75008, (Paris France) l M/sMedibios Laboratories Pvt.Ltd. Palghar-401506 (Thane) l M/s Hindustan Aritibiotics Ltd. Pune-411018(Maharashtra). l M/s Curetech Skincare Baddi-173205 (HP). l M/s GNB Medica Labs Solan-174101 (H.P.) lM/s Revat Laboratories Pvt.Ltd. Ongole-523002 (Andhra Pradesh). l M/s Algen Healthcare Limited Sirmour-173030(H.P.) l M/s Rhydburg Pharmaceuticals Ltd. Dehradun (Uttarakhand). l M/s Titans Pharma Una-174507(H.P.) l M/s Macleos Pharmaceuticals Ltd. Ranlpool-737135 (Sikkim). l M/s Glaxo SmithklinePharmaceuticals Limited Nashik-422010 (Maharashtra) l M/s CaremaxForulations Kangra-176501 (H.P.). l M/sOmate Labs Pvt.Ltd. Muzaffarpur-842005 (Bihar). l M/s Eurokem Laboratories Pvt.Ltd. Thiruporur-603110 l M/sLupin Ltd.Boisar-401506 (Palghar). l M/s SynokemPharmaceutical Ltd. Haridwar-249403 (Uttarakhand). l M/sLeben Laboratories Pvt.Ltd. Akola-444104 (Maharashtra). l M/s Jackson Laboratories Pvt. Ltd. Amritsar-143001(Punjab). l M/s Alpa Laboratories Ltd.Indore-453446 (Madhya Pradesh) - Hansraj Mehta, Mob:- 9814132529.

,D;wizs'kj dh lykg ysaokuizLFkh o FksjsfiLV t;iky flag th dk dguk gS fd os vc bl mez esa dsoy tu lsok gh djuk pkgrs gSa- 28 o"kksZa ds ,D;wizs'kjds vuqHko dks os lekt lsok esa ck¡Vuk pkgrs gSa- eksñ 09897358304] 07902030418 ij muls lEidZ fd;k tk ldrk gS-

u'kk eqfDr dsUnzks dks cwizQhuksjfiQu izkIrgksxh fliQZ flfoy ltZu vkWfiQl ls

u'kk eqfDr dsUnzks ij u'kk NqM+kus dh nok cwizQhuksjfiQu dkjsV ejhtks ls 10 xq.kk ls Hkh vf/d olwy jgs gSa- ljdkjdks bldh tkudkjh feyus ds ckn ljdkj us Bksl dnemBk, gS- blh lanHkZ esa flfoy ltZu MkWñ izHktksr dkSj tkSgyus ftys ds izkbosV u'kk eqfDr ØsUnzks ds lapkydks ds lkFkcSBd dh vkSj bl xksyh dh dher fliQZ 7-50 :i;s ghejht ls olwyus ds funsZ'k fn;s x;s- MkWñ tkSgj us ;g HkhLi"V fd;k dh ;g nok fliQZ flfoy ltZu dk;kZy; ls gh[kjhnuh gksxh vkSj blds fy;s lapkydksa dks fMekaM MªkÝVflfoy ltZu ds uke ls nsuk gksxk vkSj lapkydks dks ;s HkhLi"V djuk gksxk dh oks fdrus ejhtksa dk bykt dj jgs gSvkSj fdls bl nok dh t:jr gS- lapkydks dks vkuykbZujftLVªs'ku vkSj viuh vkbZ Mh cukus ds funsZ'k fn;s x;s gS-

Kkr jgs fd cwizQhuksjfiQu ued nok ds fy;s lapkyd vc rd ejhtksa ls 35&40 :i;solwyrs jgs gS ;g izdj.k laKku esa vkus ds ckn gh ;s dne mBk;k x;k gSa-

nok lSEiy iQsy gksus ij foHkkx dsvf/dkjh ij l[r dk;Zokgh

fgekpy ds nok fuekZrkvksa ij ljdkj dh iSuh utjeSMhdy niZ.k ehfM;k gkml dks feyh tkudkjh ds vuqlkjfgekpy izns'k esa fufeZr nok dEifu;ksa ij ljdkj us viukf'kdatk dl fn;k gS- fgekpy izns'k esa cuh nokvksa ds lSEiyyxkrkj iQsy gksus dh lwpuk ij ljdkj us ;g dne mBk;kgSaa- LOkkLF; ea=kh Jh fofiu ijekj us dgk gS fd yksxksa dsLokLF; ls f[kyokM+ vc cnkZ'r ugh fd;k tk;sxk- blh dzeesa ftu dEifu;ksa ds nok lSEiy iQsy gq, gS mUgs dkj.kcrkvks uksfVl tkjh dj fn;k x;k gS vkSj psrkouh nh x;hgS fd vxj fdlh Hkh dEiuh us vius mRikn dh DokfyVhvkSj xq.koRrk ls le>kSrk fd;k rks muds ykbZlsal jn~n djusds lkFk lkFk mudh dEiuh Hkh lhy dj nh tk;sxh- blØe esa lEcfU/r foHkkx ds Mªx bUlisDVj dh tokcnsgh Hkhdh tk jgh gS- vLirkyksa esa feyus okyh nok;s mRreDokfyVh dh gksa blds fy;s ljdkj VsaMj izfØ;k ds nkSjkunok dEifu;ksa ds fy;s WHO vkSj GNP dh lfVZfiQdsV dh vfuok;Zrk dh 'krZ Hkh tksM+h xbZ gSa-

è;ku nsa fcuk nqdku ds] FkSyk ysdj nok dk O;kikj djus okyksa ls nokbZ;ka u [kjhnsa- l ,Dlik;jh]czsdst j[kus ds fy, vyx vyekjh cuk,a ftlesa njoktk p<+k gks o rkyk yxk gks- l fcyij nokbZ dk ogh cSp uEcj tk¡p yas- l viuh lqfo/k ds fy, laHko gks lds rks dEI;wVjyxk ysa- l nokbZ;ksa ds vPNs j[k&j[kko ds fy, ,;j daMh'kuj yxk ysa- l tkudkjh feyhgS fd 'kklu ds vkns'k gSa fd jkst ,d dSfeLV dk losZ vo'; fd;k tk,- l nqdku ijxanxh u gks] fizQt esa nokbZ;ka gksa- l Fkksd foØsrk ls fcy vo'; ysa- l xzkgd ds ekaxus ijfcy ds fy, euk u djsa- l nokbZ;ksa ds Substitute de ls de nas- l xzkgdksa ls NksVh&NksVh

ckrksa ij >xM+k u djsa] 'kkafriwoZd ekeyk lqy>kus dk iz;kldjsa- l nqdku ij ykbZlSal Vkaxdj izn'kZu vo'; djsa] ns[k ysafd D;k uohuhdj.k gks x;k gS\ l dEiuh izfrfu/h ls ewY;lwph iQkeZ V ij ysdj lqjf{kr j[ksa] fcy ls jsVksa dk feykule;&le; ij djrs jgsa- l 'kqYd igq¡pkus esa nsjh u fd;kdjsa- & dSfeLV ,lksfl;s'ku eksñ 09756330600-

fgekpy izns'k ds MkWñ izrki eksgu Hkkjrh; dks feyk fgUnh Hkw"k.k Jh lEekudsñchñ fgUnh lkfgR; lferh }kjk vk;ksftr vf[ky Hkkjrh; lkfgR;dkj lEesyu 3 uoEcj dks fclkSyh(cnk¡;w) mñizñ esa lEiUu gqvk bl lEesyu esa Hkkjr ds 17 izkrksa rFkk usiky ls i/kjs lkfgR;dkjksa usf'kjdr dh- bl lEesyu esa MkWñ izrki eksgu Hkkjrh; dsk mudh d`fr mtkys dh vksj ij fgUnh Hkw"k.kJh lEeku ls uoktk x;k dsñchñ fgUnh lkfgR; lfefr ds vè;{k MkWñ lrh'k 'kekZ lq/ka'kw }kjk 'kkyJhiQy lEeku i=k] Le`fr fpUg ,oa lEeku jkf'k nsdj MkWñ izrki eksgu Hkkjrh; dks lEekfur fd;k-bl lekjksg esa mñizñ fgUnh laLFkku dh funsZ'kd MkWñ vferk nqcs eq[; vfrfFk ds rkSj ij mifLFkr jgharFkk psUubZ ls MkWñ ihñvkjñ oklqnsou (ofj"V fgUnh vf/dkjh Hkh fof'k"B vfrfFk ds :i esa i/kjs- llekjksg dk dq'ky lpkayu MkWñ fufru lsBh cjsyh }kjk fd;k x;k- MkWñ izrki eksgu Hkkjrh; jk"VªHkk"kkfgUnh ds lkFkekr`Hkk"kk fla/h esaa Hkh

lkfgR; l`tu djrs gSa-

www.medicaldarpan.com mins'k nsuk ljy gS] mik; crkuk dfBu-

dkMhZesM dk u;k mRikn

M/S Cardimed (Adivision ofPuremed Biotech) Scon. 6,Opposite City Look Hotel, SaiRoad, Baddi-173205 H.P. Email:

puremedbiotech@gmail.com Ph.

01795-244446 us gn; jksfx;ksa ds fy,u;k mRikn izLrqr fd;k gS& Rosevert CAGold-10 blesa fuEu nokvksa dk lekos'k gS-Rosuvastatzn 10mg Clopidogril75mg Asprin 75mg Rosevert CAGold 10 dSi cktkj esa 10 Cap. ds AluAlu Pack esa miyC/ gS ftldk vf/dreewY; 145=00 gS- O;kikj dh bPNqd ikfVZ;kdEiuh ds O;kikj izeq[k Jh iz'kkar eksgu lseksñ 9882011313 ij rFkk Email:

puremedbiotech12@ gmail.com

ij lEidZ dj ldrs gSa-

fu%'kqYd us=k fpfdRlk f'kfoj dkvk;kstu

fnYyh dh izeq[k lektlsoh laLFkk r:.k fe=kifj"kn }kjk vkt ;gk¡ Jh vfgPN=k ik'oZukFkfnxEcj tSu eafnj] jke uxj fdyk esa ,dfu%'kqYd us=k tk¡p o fpfdRlk f'kfoj dkvk;kstu fd;k x;k f'kfoj dk nhi iTtofyrdj 'kqHkkjaHk djrs gq, ghjk nsoh tSu VªLV dhfuns'kdk lkfjdk tSu us dgk fd r:.k fe=kifj"kn us ;gk¡ ds cqtqxks Z xjhch o xUukfdlkuksa dh lgk;rkFkZ us=k fpfdRlk f'kfojyxkdj ljkguh; dk;Z fd;k gS r:.k fe=kifj"kn ds egklfpo v'kksd tSu us crk;k fdeafnj vè;{k fouksn fcgkjh tSu ds lg;ksx lsvk;ksftr bl 121 osa us=k f'kfoj esa ds MhMkyfe;k us=k fpfdRlky; ds fpfdRlk fun-s'kd MkWñ ds yky dh vxqokbZ esa mudh Vhe}kjk 288 jksfx;ksa dh tk¡p dj nokb;k¡ iznkudh xbZ o 90 jksfx;ksa dks eksfr;kfcan dsfu%'kqYd vkWijs'ku gsrq p;u dj fpfdR;ky;ys x, ogka ij nokb;ka] ySal] p'esa vkfnlqfo/k,a fu%'kqYd miyC/ djkbZ tk,axh- f'k-foj ds vk;kstu esa eafnj vè;{k fouksn fcgkjhtSu] egkea=kh vf[kys'k tSu] la;qDr egkea=khlrsUnz tSu] latksx tSu] izcU/d vkse izdk'k]ifj"kn ds lg lfpo jkds'k tSu] fofiu tSuo jfoUnz tSu dk Hkjiwj lg;ksx feyk-

&egklfpo v'kksd tSu r:.k fe=k ifj"kneksñ 09810138138] 09266638138-

Greenleaf FormulationTablets:- CHOLEAF-60K (HOLECALCIFEROL-60000 I.UCHEWABLE TABLET IN ORANGE FLAVOUR) l LEAFCIDJUNIOR 15 (LENSOPRAZOLE 15MG DISPERSIBLE TABLETSIN ORANGE FLAVOUR) l LEAF-CID JUNIOR 30 (LENSOPRA-ZOLE 30MG DISPERSIBLE TABLETS IN ORANGE FLAVOUR)l LEAFCIN-200 (OFLOXACIN 200MG) l LEAFCIN-OZ(OFLOXACIN 200MG, ORNIDAZOLE 500MG) l GRECEFF-100(CEFIXIME 100MG DISPERSIBLE TABLETS) l GRECEFF-200(CEFIXIME 200 MG DT,LACTOBACILLUS 250 MILLIONSPORES DISPERSIBLE TABLETS) l GRECEFF-OF(CEFIXIME 200MG,OFLOXACIN 200MG) l GRECEFF-AZ 250(CEFIXIME 200MG,AZITHROMYCIN 250MG) l GRECEFF-OZ(CEFIXIME 200MG,ORNIDAZOLE 500MG) l GRECEFF-CV(CEFIXIME 200MG, CLAVULANIC ACID 125MG) l CEF-POLEAF-100 (CEFPODOXIME PROXETIL 100MG DIS-PERSIBLE TABLETS) l CEFPOLEAF-200 (CEFPODOXIMEPROXETIL 200MG DISPERSIBLE TABLETS) l CEFPOLEAF-CV (CEFPODOXIME PROXETIL 200MG, CLAVULANIC ACID125MG) l CEFPOLEAF-OF (CEFPODOXIME PROXETIL200MG, OFLOXACIN 200MG) l CEFPOLEAF-AZ (CEFPO-DOXIME PROXETIL 200MG, AZITHROMYCIN 250MG) l LEAF-CLAV-625 (AMOXYCILLIN 500MG,CLAVULANIC ACID 125MG)l LEAFCLAV-375 (AMOXYCILLIN 250MG, CLAVULANIC ACID125MG) l LEAFZOLID-600 (LINEZOLID 600MG) l FAROLEAF(FAROPENAM SODIUM EXTENDED RELEASE 200MG) l SLT-375 (SULTAMICILLIN 375MG) l AZROLEAF-250(AZITHROMYCIN 250MG) l AZROLEAF-500 (AZITHROMYCIN500MG) l LEVOFLAZ-500 (LEVOFLOXACIN 500MG) l

GREXIME-250 (CEFUROXIME AXETIL 250MG) l GREXIME-500 (CEFUROXIME AXETIL 500MG) l LEAFNIM-MD (NIME-SULIDE 100MG MOUTH DISSOLVING TABLET IN ORANGEFLAVOUR) l LEAFNIM-SPAS (NIMESULIDE 100MG, DICY-CLOMINE HCL 10MG) l LEAFNIM-P (NIMESULIDE 100 MG,PARACETAMOL 325 MG) l PAINLEAF-SPAS (DICYCLOMINEHCL 20MG, PARACETAMOL 325MG) l PAINLEAF-650(PARACETAMOL 650MG DISPERSIBLE TABLETS) l

PAINLEAF-1000SR (PARACETAMOL 1000MG SUSTAINEDRELEASE) l LEAFCAM-20 (PIROXICAM 20MG DISPERSIBLETABLETS) l LEAFLAM-PLUS (ACECLOFENAC 100MG, THIO-COLCHICOSIDE 4MG) l LEAFLAM-TH (ACECLOFENAC100MG, PARACETAMOL 325MG, THIOCOLCHICOSIDE 4MG) lLEAFLAM-P (ACECLOFENAC 100MG, PARACETAMOL325MG DISPERSIBLE TABLETS) l LEAFLAM-SP (ACE-CLOFENAC 100MG, PARACETAMOL 325MG, SERRA-TIOPEPTIDASE 15MG) l LEAFLAM-MR (ACE-CLOFENAC 100MG, PARACETAMOL 325MG, CHLOR-ZOXAZONE 250MG) l FINELEAF-P (DICLOFENACPOTASSIUM 50MG, PARACETAMOL 325MG) l FINE-LEAF-SP (DICLOFENAC POTASSIUM 50MG, PARAC-ETAMOL 325MG, SERRATIOPEPTIDASE 10MG) l FINE-LEAF-MR (DICLOFENAC POTASSIUM 50MG, PARAC-ETAMOL 325MG, CHLORZOXAZONE 250MG) l LEAF-DOL-P (TRAMADOL 37.5MG, PARACETAMOL 325MG) lFINELEAF-SPAS (ACECLOFENAC 100MG, DROTAVER-INE 80MG) l XIBOTOR-90 (ETORICOXIB 90MG TABLETCOLOUR ORANGE) l XIBOTOR-120 (ETORICOXIB120MG TABLET COLOUR MAGENTA) l XIBOTOR-PLUS(ETORICOXIB 60MG, PARACETAMOL 325MG) l

XIBOTOR-TH (ETORICOXIB 60MG, THIOCOLCHICO-SIDE 4MG) l GROWSHINE (GROW-AMINO ACID,BIOTIN, CALCIUM PANTOTHENATE, MULTIVITAMINS,MULTIMINERALS) l GREACORT-6 (DEFLAZACORT6MG) l ISOLEAF-40 (SR) (ISOXSUPRINE 40MG SUS-TAINED RELEASE) l TRYMILIN-PLUS (TRYPSIN 48MG,BROMELAIN 90MG, RUTOSIDE TRIHYDRATE 100MG,DICLOFENAC 50MG) l LEAFJOINT (DIACERIN 50MG, MSM250, GLUCOSAMINE 750MG) l GRESPAS-MF (DROTAVER-INE 80MG, MEFENAMIC ACID 250MG) l VOMNICE-MD 4(ONDANSETRON HCL 4MG MOUTH DISSOLVING TABLET INORANGE FLAVOUR) l FULANGIL-150 (FLUCONAZOLE150MG) l FABITAST-40 (FEBUXOSTAT 40MG) l THY-ROLEAF-25 (THYROXINE SODIUM 25MCG) l THYROLEAF-50 (THYROXINE SODIUM 50MCG) l THYROLEAF-100 (THY-ROXINE SODIUM 100MCG) l ZINTOLEAF-COLD (PARACETA-MOL 325MG, LEVOCETIRIZINE 2.5MG, PHENYLEPHRINE10MG, CAFFEINE 30MG) l LEAFNIM-CC (NIMESULIDE100MG, PARACETAMOL 325MG, PHENYLEPHRINE HCL 10MG,CETIRIZINE HCL 5MG, CAFFEINE 25MG) l ZINTOLEAF (LEV-OCETIRIZINE 5MG) l ZINTOLEAF-M KID (LEVOCETIRIZINE2.5MG, MONTELUKAST 4MG) l ZINTOLEAF-M (LEVOCETI-RIZINE 5MG, MONTELUKAST 10MG BILAYERED TABLET) l

ZINTOLEAF-AM (LEVOCETIRIZINE 5MG, AMBROXOL 60MG) lZINTOLEAF-PLUS (LEVOCETIRIZINE 5MG, MONTELUKAST10MG, ACEBROPHYLLINE 200MG (SR) l ZINTOLEAF-FORTE(LEVOCETIRIZINE 5MG, MONTELUKAST 10MG, AMBROXOL75MG) l FEXOGREN-M (FEXOFANADINE120MG,MON-TELUKAST 10MG BILAYERED TABLET) l LINHISTIN-16(BETAHISTINE 16MG) l PREGALEAF-SR (PREGABALIN75MG SUSTAINED RELEASE), METHYLCOBALAMIN1500MCG) l LEAFCOB-NT (PREGABALIN 75MG, NOR-

TRIPTYLINE10MG) l LEAFCOB-ALA (MECOBALAMIN1500MCG, ALPHA LOPIC ACID 100MG, FOLIC ACID 1.5MG,PYRIDOXINE 3MG, THIAMINE 10MG) l LEAFCOB-MNT (PRE-GABALIN 75MG, METHYLCOBALAMIN 1500MCG, NOR-TRIPTYLINE10MG) l LEAFPRIN-40SR (ISOXSUPRINE40MG(SR) l PLEAF-40 (PANTOPRAZOLE 40MG) l PLEAF-D(PANTOPRAZOLE 40MG, DOMPERIDONE 10MG) RABLEAF-20 (RABEPAZOLE 20MG) l RABLEAF-D (RABEPAZOLE20MG, DOMPERIDONE 10MG) Mob.:- +91 9317777888.

Farma HubTablets:- Akon-Xt (Ferrous Ascorbate Eq. to Lron 100mg + FolicAcid 1.5mg) l Amress-Al (Amlodipine 5 gm + Atenolol 50 mg) lAnlin-400 (Theophyllin Prolonged Rekease Ip 400 mg) l

Azixime (Azithromycin 250 mg + Cefixime 200 mg) l AziximeLB (Azithromycin 250 mg + Cefixime 200 mg + Lactic Acid 60

Million Spores) l Azixime Plus (Azithromycin 500 mg + Cefixime200 mg) l Candifine Tf (Ltraconzole 100 mg + Terbinafine 250mg) l Cefafar 250 Cefuroxime Axetil 250mg) l Cefafar 500Cefuroxime Axetil 500mg) l Cefafar Cv 250 (Cefuroxime Axctil250mg + Potassium Clavulanic 125mg) l Cefafar Cv 500(Cefuroxime Axetil 500mg + Potassium Clavulanic 125mg) lCefizan Plus (Cefixime 200mg + ofloxacin 200mg) l Cefizna S(Cefixime 200 mg + Sulbactam 150 mg) l Cefiway 200 Bb(Cefixime 200 mg + Lactic Acid 60 Million Spoers) Cefiway Plus(Cefixime 200mg + Ofloxacin 200mg + Lactic Acid Bacillus) lCefiway Oz (Cefixime 200mg + Omidazole 500mg) l Chestwin(Paracetamol 325mg + Cetirizine 5 mg + Phenylephrine10mg) lClonazan-Et (Clonazepam 0.5mg + Escitalopram Oxalate 10mg)l Defahub 6 (Deflazacort 6mg) l Doxyfine (DoxylamineSuccinate 10mg + Pyridoxine Hydrochloride 10 mg) l Drotyfar-M

(Drotaverone Hcl 80mg + Mefanamic Acid 250mg) l Etohub 0.5(Etizolam 0.5 mg) l Etohub 0.25 (Etizolam 0.25 mg) l Ex-Cv 375(Amoxycillin Trihydrate 250mg + Clavulanic Acid 125mg) l Ex-Cv625 (Amoxycillin Trihydrate 500mg + Clavulanic Acid 125mg) lEx-Cv 625 Lb (Amoxycillin Trihydrate 500mg + Clavulanic AcidBacillus) l Farchav-375 (Amoxycillin Trihydrate 250mg +Clavulanic Acid 125mg) l Farchav-625 (Amoxycillin Trihydrate500mg + Clavulanic Acid 125mg) l Farclav-Kid (AmoxycillinTrihydrate 200mg + Clavulanic Acid 28.5mg) l Farcof Cold(Paracetamol 325 mg + Guaiphenesin 100 mg + Ambroxol 30mg+ Phenylephrine 10 mg + Cpm 10 mg) l Farcort 4(Methyleprednisolone 4 mg) l Farcort 8 (Methyleprednisolone 8mg) l Farcort 16 (Methyleprednisolone 16 mg) l Farcoxia(Etoricoxib 90 mg) l Farnac-forte (Trypsin 48mg + Bromelain90mg + Rutoside 100mg + Diclofenac Potassiun 50mg l Farna-p Aceclofenac 100mg + Paracetamol 325mg) l Farnac-p (Alu-Alu) (Aceclofenac 100mg + Paracetamol 325mg) l Farnac-Mr(Aceclofenac 100mg + Paracetamol 325mg + Chlorzoxazone250mg) l Farnac-sp (Aceclofenac 100mg + Paracetamol 325mg+ Serratiopeptidase 15mg) l Faranc-th4 (Aceclofenac 100mg +Paracetamol 325 mg + Thiocolchicoside 4mg) l Farpod-O(Cefpodoxime Proxetil 200mg + Ofloxacin 200 mg) l Farpod 100(Cefpodoxime Proxetil 100mg) l Farpod 200 (CefpodoximeProxetil 200mg) l Farpod CV (Cefpodoxime Proxetil 200 mg +Pot. Clavulanate 125mg) l Farzyme Pancreatin 170 mg +Activates Dimethicone 80 mg) l Febufar 40 (Febuxostate 40 mg)l Fixim 100 Dt (Cefixime Trihydrate 100mg) l Fixim 200 Dt(Cefixime Trihydrate 200mg) l Fixim 400 (Cefixime Trihydrate400mg) l Fixim-Lb 50 Dt (Cefixime With Lactic Bacillus 50mg) lFixim Plus (Cefixime Trihydrate 200mg + Ofloxacin 200mg) lFungifar 250 (Terbinafine 250 mg) l Fungifar 500 (Terbinafine500 mg) l Glyzan M1 (Glimepride 1 mg + MetforminHydrochloride 500 mg) l Glyzan M2 (Glimepride 2 mg +Metformin Hydrochloride 500mg) l Glyzan Mv1 (Voglibose0.1mg + Glimepride 2.0mg + Metformin Hydrochloride 500mg) lGlyzan Mv2 (Voglibose 0.2 mg + Glimepride 2.0 mg + MetforminHydrochloride 500 mg) l Ishufee (Flupentixol 0.5 mg +Melitracen 10 mg) l Joycin-500 (Levofloxacin 500mg) l JoycinOz (Levofloxacin 250mg + Ornidazole 500 mg) l Kalen (CalciumCitrate 100mg + Calcitrol 0.25mg) l Kalen K2 + (Vitamin K2745mcg + Calcium Citrate 1000mg + L-Methylfolate 1mg + CissusQuadrangularis 500 mg + Vitamin D3 1000 Ui) l Le-Jig

(Levocetrizine 5 mg) l Linifine (Linezolid 600 mg) l

Lumefar (Artemether 80mg + lumefantrine) l Metfar-500(Metformin 500 mg) l Moxyzan 250 DT (AmoxycillinDispersible Tablets 250 mg) l Necfine-p (DiclofenacSodium 50 mg + Serratiopeptidase 10mg + Paracetamol325mg) l Nipafar (Nimesulide 100mg + Paracetamol325mg) l Ketofar (Ketoconazole 200 mg) l Panfar 40(Pantoprazole 40 mg) l Panfar D (Pantoprazole 40 mg +Demeperidone 10 mg) l Parahub 650 (Paracetamol 650mg) l Parahub D (Paracetamol 325 mg + Demoperidone 10mg) l Rabyfar 20 (Rabeprazole 20 mg) l Tamsufar-D(Tamsulosin 0.5 mg + Dustasteride 0.4 mg) l Tanmink 20(Telmisarten 20 mg) l Tanmink 40 (Telmisartan 40 mg) lTanmink 40 H (Telmisartan 40 mg + Hydrochlorothiazide12.5 mg) l Texazan- MF (Tranexamic Acid 500 mg + Mefenamic Acid 250 mg) l Tenzan(Trifluoperazine HCL 1 mg + Chloradiazepoxide 10 mg) lTenifar-20 (Teneligliptin Hydrobromide hydrate 20 mg) lTenifar-M (Teneligliptin Hydrobromide hydrate 20 mg +Metformin 500mg) l Udifine 150 (Ursodeoxycholic Acid150mg) l Udifine 300 (Ursodeoxycholic Acid 150mg) lUdifine 300 (Ursodeoxycholic Acid 300mg) l Udifine SL(Ursodeoxycholic Acid 300mg + Silymarin 140 mg) l

Vertizan 8/16 (Betahistine Hydrochloride Tablets IP 8 mg/16mg) l Veebaz 250 (Azithromycin Dinhydrate 250mg) l

Veebaz 500 (Azithromycin Dihydrate 500mg) l Veebaz 500 Lb(Azithromycin Dihydrate 500mg + Lactic Acid Bacillus) l

Vomifine (Ondansetron 4 mg) l Windfar-Fx (MontelukastSodium 10mg + Fexofenadin Hydrochloride IP120mg) l

Windfar-L (Levocetrizine HCL 5mg + Montelukast Sodium 10mg) l Wisoflox 200 (Ofloxacin 200mg) l Wisoflox-oz (Ofloxacin200mg + Ornidazole 500mg) l Xcitement (Jar) Sildenafil Citrate100 mg) l Xcitement (Strip) Sildenafil Citrate 100 mg) l

Zanofiram (Disulfiram tablets IP) l Zan-M-Spas (Mefenamic Acid250 mg + Dicyclomine Hydrochloride 10 mg) l Zincofar(Vitamins + Minerals + Natural Extract + Nutritional foodSuppliments) Capsules:- Candifine (Itraconazole 100 mg) lCandifine-200 (Itraconazole 200 mg) l Cindaplay-300(Clindamycin 300 mg) l Dirham (Omeprazole 20mg)

Mob:- 08171011413, 09837187230.

Product List

E-derma Pharma India Pvt. Ltd. Antibiotics - AZICA Tablet : Azithromycin 250/500mg l AUG-FAST Tablet : (Amoxycillin Trih 500mg Potassium Clav. 125mg)l MINOPEARL Tablet : (Minocycline 50/100mg) l METATURNOintment : (Mupirocin 2%) l CEFITURN Tablet : (Cephalexin500 mg) l DALLOX Capsule : (Amoxycillin 250 mg &Dicloxacillin 250 mg) l DYNACLIN Tablet : (Clindamycin150/300 mg) l l DOXYAID-LB Capsule : (Doxycycline Hyclate100mg and 5 billion lactobacillus spores) l FUDICA Cream :(Fusidic acid 2%) l NADIREST Cream : (Nadifloxacin 1%)Antiallergic- E-BEST Tablet : Mizolastine 10 mg l HYBEST-10/25 Tablet : (Hydroxyzine 10/25 mg) l LORAID Tablet :(Loratadine 10 mg) l LEVOCA Tab/Syp : (Levocetirizine 5 mg) lLEVOCA-M Tablet : (Levocetirizine 5 mg & Montelukast 10mg)l POLBEST Tablet : (Dexchlorpheniramine SR 2mg) l FEX-UPTablet : (Fexofenadine 180 mg) l CALOMYNE Lotion :(Calamine 8%, Glycerin 5%, Aloevera 10% ,Liq. Paraffin , ZincOxide 3%) Steroids - DYNACORT Tablet : (Deflazacort6/12/30mg) l SAFECORT Cr/Lot. : (Mometasone Furoate 0.1%)l ECZIVATE 30 Cream : (Clobetasol Prop. 0.05%) l OFICACream : (Fluticasone 0.05%) l HALOTURN Cream :(Halobetasol Prop. 0.05%) l FLUTURN-H Cream :(Fluocinolone Acetonide 0.1%) l NADIREST-M Cream :(Nadifloxacin 1% & Mometasone 0.1%) l DESOCARE Lotion :(Micronised Desonide 0.05%) l ECZIVATE-S Lotion :(Clobetasol 0.05% & Salicylic Acid 3/6%) l HALOTURN Lotion :(Halobetasole Propionate 0.05%) l ISORVATE-AL Gel :(Clobetasol prop. 0.05%, Ammonium Lactate 12%) l FUDICA-BCream : (Fusidic acid 2% & Mometasone Furoate 0.1%)Antifungal - ITRASTAT Capsule : (Itraconazole 100/200mg) lTERBAZ Tablet : (Terbinafine 250 mg) l TERBAZCr/Dust. Powder : (Terbinafine 1%) l KTZ Tablet: (Ketoconazole 200 mg) l KTZ Cr/Dust. Powder: (Ketoconozole 2%) l KTZ Lotion : (Ketoconazole2% Stay on Lotion) l CANBEE Cream :(Clotrimazole 1% , CANBEE-B Cream :Clotrimazole 1% & Beclomethasone 0.025%,SERTAFIX Cream : (Sertaconazole 2.0% & Benzylalcohol 1.0%) l K-WASH Shampoo :(Ketoconazole 2%) l K-WASH PLUS Shampoo :(Ketoconazole 2% & ZPTO 1%) l FLUPACKTablet : (Fluconazole 150 mg) l VORBERG Tablet: (Voriconazole 200 mg) l LUNICOL Cream :(Luliconazole 1%) l AMLOTURN Cream :(Amorolfine 0.025%) Immunosuppressants –AZONY Tablet : (Azathioprine 50 mg) l TACROG-ARD 0.1/0.03 Ointment : (Tacrolimus 0.1/0.03%) lSORAPRIN Softgel Capsule : (Cyclosporine100mg) l NEOTURN 2.5/5/7.5 Tablet :(Methotrexate 2.5/5/7.5 mg) Acne Care - ISO-PEARL-M20 Softgel Cap : (Micronised Isotretinoin20mg) l ISOPEARL-10/20 Softgel Cap :(Isotretinoin 10/20mg) l ISOPEARL-30 SoftgelCap : (Isotretinoin 30mg) l ISOTY Softgel Cap. :(Isotretinoin 20 mg) l DYNACLIN-N Gel :(Clindamycin 1% & Nicotinamide 4%) l DYNACLINGel : (Clindamycin 1%) l O-GYL Gel : (Ornidazole10 mg) l ADAQUEEN Gel : (Adapalene 0.01%) lADAQUEEN-C Gel : (Adapalene 0.01% &Clindamycin 1%) l TRET-A Cream : (Tretinoin0.025%) l AZICA Gel : (Azithromycine 2%) l BEN-ZITURN-AD Gel : (Adapalene 0.1% % benzoyl per-oxide 2.5%) l Benziturn -2.5/5/10 Gel : (Benzoylperoxide 2.5/5/10%) Hyperpigmenting Agents -AZESPOT Cream : Azelaic acid 15 % l FACELITEGel : (Kojic Acid 2%, Arbutin 1.5%, Octinoxate7.5%, Mulberry Extract & Glycolic Acid) l M-LITEPLUS Cream : (Hydroquinone 2%, Tretinoin0.025%) l M-LITE FORTE Cream : (Hydroquinone2%, Tretinoin 0.025% & Mometasone 0.1%) l M-LITE GLOW Cream : (Hydroquinone 2%,Tretinoin0.025% & Fluocinolone Acetonide 0.01%)l M-LITE AT Cream : (Hydroquinone 2%, Tretinoinand Allantoin) l M-LITE Cream : (Hydroquinone2%) l MELOSPOT Cream : (Hydroquinone 4%) lLITEFACE Cream : (Depigmenting Cream) l

GLOW DAY Cream : (Glycolic acid, Alpha Arbutin,Tocopheryl acetate, Resorcinol, Titanium Dioxide) l

GLOW NIGHT Cream : (Alpha Arbutin, Retinol, Liquorice, Vit. E,Glycerine, Squalene, D- alpha Tocopherol, Lenolin) l GLUTA-GLOW Tablet : (Glutathione 500mg and Lipoic acid 200mg) lGLUTAGLOW-C Tablet : (Glutathione 500mg & Vitamin-C500mg) l GLUTAGLOW Peel : (Glutathione 1%, Glycolic acid45%, Lactic Acid 10%, Salicylic acid 0.5%, Kojic Acid Dipalmitate7%, Lemon Peel Ext. 2%, Butyospermum Parkii 5%) l GLUTA-GLOW-C Serum : (Ethyl Ascorbic Acid Stable Vit. C 20%,Glutathione 2%, Niacinamide 2%, Beta-Arbutin 2%, Orange PeelExtract 2%, Lemon Peel Ext. 2%, Dimethicone 2%, ChamomilaExt. 2%) Antioxidants/ Vitamins - LYCOXID Tablet :(Betacarotene (10%) 30 mg, Lycopene (10%) 7500 mcg, Vit. C150 mg., Vit. E 25 mg, Minerals & Zeaxanthine (10%) 25 mg) lPROCDINA Tablet : (Proanthocyanidin 75 mg) l PROCDINA-TX Tablet : (Tranexamic acid 250 mg) l IRONI UP Capsule :(Carbonyl Iron 100 mg, Vit. C 150 mg, Vit. B12 15 mcg., Folic Acid5 mg, Zinc Sulphate 61.8 mg & Vit B6 3 mg) Hair Care - FIN-TURN Tablet : (Finasteride 1 mg) l BIOTURN FORTE Tablet :(Biotin 10 mg, Calcium Pantothenate 100 mg, N-Acetyl Cysteine50 mg, Minerals) l MINTURN-XL Lot/Spray : (Minoxidil 5% &Aminexil 1.5%) l MINTURN-2/5/10 Lot/Spray : (Minoxidil2/5/10%) l HAIR LONG Oil : (Sun flower Oil, Olive Oil, Amla Ext.,Castor Oil, & Grapeseed Oil) l HAIR LONG Tablet : (Beta –Sitosterol 100mg, Manganese 2mg, Vit. E 5mg, Green tea 50mg,Ginkgo biloba 10mg, Nettle leaf extract 50mg, Amino acid,Vitamin B6 3mg, Collagen peptide 50mg & minerals) l HAIRLONG Serum : (Procapil, Keravis, Hydroxyethylcellulose, TributylCitrate, Germall, Propylyene Glycol, Polyquaternium) l HairLong B + Oil : (Biotin, saw palmetto, D -panthenol, SugandhaKokila, Seasame oil, roots of karonday, olive oil) l SOFTUM

Shampoo : (Shea Butter, Ceramides, Soya protein) Soap/Facewash - E-BACTY Soap : (Vit. E, Allantoin & Alum) l ACNE-DAY Soap : (Triclosan, Triclocarben, Glycerin, Vit. E, Aloe Vera& Tree Tea Oil) l GLOWBELLA ALOE VERA Soap : (Aloevera,Vitamin-E, Acetate & Glycerin) l KTZ Soap : (Ketoconazole 1%,ZPTO 0.5%) l SCABICA Soap : (Permethrin 1%) l BEAUTYBar : (Aloe vera, Milk protein, Shea butter, Cocoa butter, Titaniumdioxide, Almond oil, Tree Tea Oil, Vit. E) l GLOWBELLA SOAPSkin Whitening : (Kojic acid, Arbutin, VIT A,C,E & F, Liquorice,Bearberry and Mushroom Extracts.) l SOFTUMBABY/Moisturizer Bar pH 5.5 : (Vit E, Syndet Base, SheaButter, Aloe Butter, Aloe Vera) l VISIA Soap : (Aloe Vera, Vit. E& Moisturising) l VISIA Facewash : (Lemon, Honey, Menthol,Mulberry Extracts) l ACNEDAY Facewash : (D-panthenol,Salicylic, Allantion, Witch Hazel, Aloe vera, Vit E & Triclosan) lSOFTUM Cleansing Lot. : (Cetyl Alcohol 2.65% and stearyl alco-hol 0.265) l GLOWBELLA Skin Whitening Facewash :(Salicylic, Kojic, Lactic and and Glycollic acid) Emollients - VISIACr/Lot. : (Glycerine 6.0%, Tocopheryl Acetate 0.5%, LiquidParaffin 10.0%, Cetyl Alcohol 3.0%, Squalene & Aloe Vera) lVISIA Soft Cream : (Propylene Glycol, Emulsifying wax,Glycerin, Cyclomethicon, ZnO CREAM) l VISIA Lip Balm : (LipCare Lip Balm) l GLOW BELLA moisturizing LOT : (GlycerylMonostearate, Glycerol, Caprylic/Capric Triglyceride, Aloe,Barbadensis Leaf Juice, Stearic Acid, Cetaearyl Alcohol,Butyrospermum Parkii (Shea Butter), Cyclopentasiloxane,Ethylhexylglycerin, Sodium PCA, Tocophery Acetate, DisodiumEDTA, Disodium EDTA, Allantoin For sensitive skin) Sunscreen -O' BAY SPF 30 + Sunscreen : (Octylmethoxycinnamate 5.0%,Avobenzone 2.0%, Methoxy Cinnamidopropyl Hydroxy Sultaine

2.0%, Zinc Oxide 2.0%, Allantion 0.2%, Vitamin E0.1%, Aloe Vera Gel 0.2%, Titanium Dioxide 2%) lVISIA SPF 50 + Sunscreen : (Octinoxate 7.5%,Avobenzone 2%, Oxybenzone 3%,Octocrylene 3%,ZnO 2%, Titanium dioxide 3%) Psoriasis Care –TARSOFT-CS Ointment : (Clobetasol 0.05%,Salicylic Acid 3% & Coal Tar 5%) l ECZIVATE-MFOintment : (Clobetasol 0.05%, Salicylic Acid 3%,Urea 10% & Lactic Acid 3%) l TARSOFT Lotion :(Coal Tar 4.25% & Salicylic Acid 2%) l TARSOFTOintment : (Salicylic Acid 3% & Coal Tar 6%) lCallove Ointment : (Calicipotriol 0.005%)Antiscabies - IVITURN Tablet : (Ivermectin 6/12mg) l PERISH Cream/Lotion : (Permethrin 5%)Antiviral – F-VEER Tablet : (Famciclovir 250mg)Misc - D2 PLUS Tablet : (Diclophenac 50mg,Paracetamol 325 mg & Serratiopeptidase 15mg) lPAPSODOM Tablet : (Pantoprazole 40 mg. &Domperidone 10 mg) l FOUR STROKE Cream :(Ofloxacin 0.75%, Ornidazole 2%, Terbinafine 1% &Clobetasol Prop. 0.05%) l NEW LAUNCH :(MELOSPOT CREAM : Hydroquinone 4%,Octinoxate, Oxybenzone & Titanium Dioxide)

Mob:- 09034435000 09034635000.

SHERYA GERICAREA DIVISION OF SBS BIOTECH

CARDIAC RANGE:- AMOFINE-2.5 (Amoldopine2.5 mg Tab) l AMOFINE-5 (Amlodipine 5 mg Tab) lAMOFINE-10 (Amlodipine 10 mg Tab) l

AMOFINE-AT (Amlodipine 5 mg +ATENOLOL50MG Tab) l AMOFINE - H (Amoldopine 5 mg +Hydrochlorothiazide 12.5mg Tab) l ATINO-25(Atenolol 25 mg Tab.) l ATINO-50 (Atenolol 50 mgTab.) l ATVOC-10 (Atorvastatin 10mg Tab) l

ATVOC-20 ( Atorvastatin 20mg Tab) l ATVOC-40(Atorvastatin 40mg Tab.) l ATVOC-80 ( Atorvastatin80mg Tab.) ATVOC-EZ ( Atorvastatin 10mg +Ezetimibe 10mg Tab) ATVOC-F ( Atorvastatin 10mg+ finofibrate 160 mg Tab(as beta-cyclodextrin)) lATVOC AD -15 (Atrovastatin 10mg + Amlodipine 5mg) l ATVOC AS 85 ( Atrovastatin10mg & AsprinCapsules75mg) l CARNEB-2.5 (Nebivolol 2.5 mgTab.) l CARNEB-5 (Nebivolol 5 mg Tab.) l

CARNEB-H (Nebivolol 5 mg + Hydrochlorthiazide12.5mg Tab) l CLOPU (Clopidogrel 75mg Tab) lCOREL-75 A (Clopidogrel 75mg + Aspirin 75 mgTab) Mob:- 9541810111.

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds tks fd iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj ds uke ls gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsa-

www.medicaldarpan.com

Product List

D.O.B. NAME FIRM MOB. CITY STATE

21.11.65 SHRI SANJAY KUMAR GARG JI NAGPAL MEDICINE TRADERS 9810734393 FARIDABAD HARYANA

21.11.89 SHRI ANIL GUPTA JI HANS MEDICAL AGENCY 9027150705 BARAUT UTTAR PRADESH

24.11.77 SHRI ASHISH SHARMA JI GANPATI HEALTH CARE 9416422455 REWARI HARYANA

24.11.80 SHRI AMIT JAIN JI KATNI CHEMIST 9685623633 KATNI MADHYA PRADESH

27.11.84 SHRI ANKIT SINGHAL JI SHIV SHAKTI MEDICOSE 9813066386 JAJJAR HARYANA

10.12.78 SHRI AMIT MITTAL JI USHA MEDICAL AGENCY 9826620402 SHIVPURI MADHYA PRADESH

15.12.74 SHRI ASHOK KUMAR JI ASHA PHARMA 9534374380 GAYA BIHAR

eSMhdy niZ.k ehfM;k gkÅl dh rjiQ ls vki lHkh dks tUe fnu dh gkfnZd 'kqHkdkeuk;sa

Happy Birthday

uoEcj o fnlEcj ekg ds R;kSgkj22-11-2019 mRiUuk ,dkn'kh23-11-2019 xkS.k mRiUuk ,dkn'kh] oS".ko mRiUuk ,dkn'kh24-11-2019 iznks"k ozr25-11-2019 ekfld f'kojkf=k26-11-2019 ekxZ'kh"kZ vekoL;k] n'kZ vekoL;k27-11-2019 pUnz n'kZu30-11-2019 fouk;d prqFkhZ01-12-2019 fookg iapeh] ukx iapeh 02-12-2019 lqczgeU; "k"Bh] pEik "k"Bh04-12-2019 ekfld nqxkZ"Veh08-12-2019 eks{knk ,dkn'kh] xhrk t;Urh

eRL; n~okn'kh] xq:ok;qj ,dkn'kh09-12-2019 iznks"k ozr] guqeku t;Urh10-12-2019 dkfrZxkbZ nhie~11-12-2019 nRrk=ks; t;Urh] iwf.kZek miokl] jksfg.kh ozr12-12-2019 ekxZ'kh"kZ iwf.kZek] vUuiw.kkZ t;Urh] f=kiqj HkSjoh t;Urh13-12-2019 ikS"k izkjEHk15-12-2019 lad"Vh prqFkhZ16-12-2019 /uq laØkfUr19-12-2019 dkyk"Veh

COPD ls djs cpkoØkWfud vkWClVªfDVo iYeksujh fMtht (lhvksihMh) ,d chekjh ugha gS cfYd chekfj;ksa dk lewg gS- blesa lk¡l uyh dh fldqM+ tkrh gS ftlds dkj.k iQsiQM+s Hkh MSest gksus yxrs gSa ftls ,EiQk;lsek dgrs gSa- ;g chekjh lcls igyslk¡l ysus esa :dkoV iSnk djrh gS- vkSj blds ckn gkVZ o fdMuh vkfn nwljs vaxks dks Hkh uqdlku igqapkrh gSa- ;g chekjh Leksfdax vkSj Leksfdax u djus okys nksuksa esa gksus okyh chekjh gS- lhvksihMh ds y{k.k vkerkSj ij 30 o"kZdh mez ds ckn fn[krs gSa- 'kq: esa lnhZ ds ekSle esa [kkalh] cyxe vkrk gS- blds ckn vDlj lnhZ&tqdke dh leL;k jgrh gS- rhozrk cM+us ij lkal m[kM+rh gS- /weziku djus okys esa lcls vf/d [krjk jgrk gS- /q,a ls ;g chekjhvf/d gksrh gS- ysfdu 40 izfr'kr ,sls ejht gSa tks Leksfdax ugha djrs gSa- /weziku djus okyk vLFkek dk jksxh gS rks mlesa [krjk vf/d jgrk gSa- bl chekjh dk iznw"k.k Hkh cM+k dkj.k gSa- xkaoksa esa pwYgksa ij [kkuk cukus okyhefgykvksa dks [krjk jgrk gS- ,sls O;kikj tgka] /qa, vkSj dSfedy dh xa/ vf/d gksrh gS- blls Hkh [krjk vf/d jgrk gS- blesa iQsiQM+ksa dks uqdlku gksrk gS- /weziku djus okys 4 esa ls ,d O;fDr dks lhvksihMh gksrk gS- /wezikuNksM+ nsa- ?kj esa dhVuk'kd dk fNM+dko ;k jax dk dke py jgk gS rks nwj jgsa- iznwf"kr {ks=kksa esa tkus ls cpsa- fdpu ds /q,a vkSj elkyksa dh xa/ ls cpsa- lk¡l ysus okys O;k;ke fu;fer djsa- bl jksx ls iQsiQM+ksa dh {kerk ?kVrh gSbldks Bhd djus ds fy, bUgsyj dk bLrseky fd;k tkrk gS- iQsiQM+ksa esa laØe.k Hkh vf/d jgrk gS- blesa iwjk iQsiQM+k dke ugha djrk gS rks 'kjhj esa vkWDlhtu dh deh gksrh gS- blds fy, chp&chp esa vkWDlhtu nh tkrh gS-blds vykok tc yax vVSd esa bUgsyj dke ugha djrk gS rks ejht dks d`f=ke lk¡l nsrs gSa [kjkc iQsiQM+ksa dks cqykDVeh esa dkVdj Hkh bykt fd;k tkrk gS- ;g lqfo/k vius ns'k esa Hkh gS- t:jr ds vuqlkj gkVZ dh rjg yaXl esaHkh LVsaV Mkydj bykt fd;k tkrk gS- blesa jksfx;ksa dks ikSf"Vd ,oa larqfyr vkgkj ysuk pkfg,- buesa ,aVh&ck;ksfVd] ,aVhbaÝykesVjh ,oa ,aVh&vkWDlhMsaM~l xq.k okyh phtsa [kk,a- otu c<+us ls ijs'kkuh c<+rh gS- ,sls esa gkbZ izksVhu o yksdSyksjh okyh phtsa gh [kkuh pkfg,- ftudk otu vf/d gS os yks dSyksjh MkbV ysa- blesa rkts iQy [kkus dkiQh ykHknk;d fl} gksrs gSa- tks iQsiQM+ksa ds van:uh elYl dks LoLFk j[krsa gSa vkSj vanj ds uqdlkunk;d inkFkksZ dks ckgjfudkyrs gSa- blfy, gj ekSle ds rkts iQyksa ,oa lfCt;ksa dks Hkjiwj ek=kk esa MkbV esa 'kkfey djsa- MkWñ lw;ZdkUr] ofj"B lkal jksx fo'ks"kK vkSj foHkkxkè;{k-

www.medicaldarpan.com

November 20-22, 2019 HOSPEX Japan 2019 Koto, Japan. HOS-PEX Japan, held in conjunction with the Conference Healthcareof Engineering Association of Japan, is a comprehensive exhibi-tion including hospital-based facilities, equipment and engineer-ing resources; health and medical treatment information systems;and healthcare and welfare services and support systems. It willbe held at Tokyo Big Sight, Koto, Japan. For details contact:JapanManagement Association, 3-1-22 Shiba Koen, Minatoku,Tokyo 105- 8522, Japan. Tel.: +81-3-3434-1377, Email: hos-pex@convention.jma.or.jp Website: www.jma.or.jp

November 22-24, 2019 Emirates Dermatology Society AnnualConference 2019 Dubai, UAE.The aim of Emirates DermatologySociety Conference 2019 is to provide a forum of the higheststandard for scientific, educational and social exchange betweenprofessionals involved in Dermatology are in order to achieveprogress in the clinical care of patients. It will be held atInterContinental Dubai Festival City, UAE. For contact details:K.I.T. Group Middle, East FZ LLC, P.O. Box: 77893, TwoFour 54Building, Abu Dhabi, UAE.. Tel.: +971-2245-0057, Email:info@edsuae.com ; Website: www.conference.edsuae.com

November 27-28, 2019 Africa Healthcare Extension Summit2019 Nairobi, Kenya. The 2nd edition of Africa HealthcareExtension Summit will include world class speakers from thehealthcare industry to provide an inside access to what works

today and future trends that will shape and revolutionize thehealthcare sector in Africa region. For details contact: VerveManagement, 2501, HDS Tower, Cluster F, Jumeirah LakesTowers, Dubai, United Arab Emirates. Tel.: +971-4-243-4677/88,E-mail: info@verve-management.com Website:

http://www.vervemanagement.com

November 29-30, 2019 International Oncology Conference 2019Abu Dhabi, UAE. International Oncology Conference features aninterdisciplinary approach, special lectures, debates and interac-tive techniques to explore the controversial, the upcoming, theexciting and the latest evidence and developments in the manage-ment and treatment of Breast, Colon, Lung, Gynecological,Urological, Hematological and Pediatric Cancers. It will be held atGrand Hyatt Hotel & Residences Emirates Pearl, Abu Dhabi,UAE. For details contact: Mena Conference LLC, Office 504,Abdullah Bin Darwish Bldg. HamdanSalam, St. Junction, AbuDhabi-54210, UAE. Tel.: +971-2491-9888, Email: afsal.@mena-conference.com Website: www.menaconference.com/events/7ioc

December 2-6, 2019 ZDRAVOOKHRANENIYE 2019 Moscow,Russia. International Exhibition for Health Care, MedicalEngineering and Pharmaceuticals will be held at Expocentre,Moscow, Russia. For details contact: Expocentre,14,Krasnopresnenskaya nab, Moscow- 123100, Russia. Tel.:+49-211-4560-7734, Email: TervielD@messeduesseldorf.deWebsite: www.zdravo-expo.ru/en

December 2-3, 2019 Food Microbiology Congress 2019 London,UK. Conference Series Ltd invites all the participants across the

globe to attend Global Summit On Food Microbiology & Nutritionwhich includes prompt keynote presentations, Oral talks, Posterpresentations and Exhibitions. Food Microbiology Congress 2019is a specially designed food and nutritional research Conference.The main theme of this pharma conference is “Advancement in

Food Microbiology and Nutrition” which covers a wide range ofcritically important sessions. It will be held in London, UK. Fordetails contact: Conference Series LLC Ltd., 47, Church fieldRoad, London, W3 6AY, UK. Tel.: +44-203-7690-972, E-mail:ffoodmicrobes@expertmeetings.com ; Website: https://www.foodmicrobiology. microbiologyconferences.com/

December 4-5, 2019 UKRAI Pharmaceutical 2019 Kyiv, Ukraine.Ukrainian Pharmaceutical Forum focuses on topics such asreform of healthcare system in Ukraine, regulatory changes in theUkrainian pharmaceutical market, trends in the development ofthe pharmaceutical sector globally and their adaptation inUkraine, investment attractiveness of the pharmaceutical marketin Ukraine, and much more. It will be held at InterContinentalHotel, Kyiv, Ukraine. For details Contact: Adam SmithConferences, 14, Gray’s Inn Road, London, WC1X 8 HN, UnitedKingdom. Tel.: +380-63- 7673207, E-mail: A.Kuzminskaya@adamsmithconferences.com Website:www.pharmaukraine.com

December 5-7, 2019 Vietnam Medi Pharm Expo 2019 Hanoi,

Vietnam Vietnam Medi-Pharm Expo is a platform for the world

advanced medical technologies and equipment companies to

access local private and public hospitals and local pharmaceuti-

cal companies which Vietnam hasadvantages to exchange. For

details contact: VINEXADExhibition & Event, 9 Dinh Le, Hanoi,

Vietnam. Tel.: +84-24-3825- 5546, Email: thaituyethuong@

vinexad.com.vn Website: http://

www.hcm.medipharmexpo.com

FORTH COMING EVENTS

AUTHORIZED DISTRIBUTORS

OF ADR Book

Location Shop Name Contact No.

Agra Satish Book Enterprises 9997877123

Allahabad Friends Book Depot 9451743891

Amritsar Rajat Book corner 9417381838

Amritsar Sunder Book Depot 9814074241

Barnala Navchetan Book Shop 9779050692

Dhule Kushal Book shop 9423916592

Dimapur Modern Book Depot 9436006701

Gwalior Unique Book Depot 9826257932

Haldwani Pooran & Sons 9837092823

Jodhpur Book World 9829088088

Kolkata Medicare Book House 9830518610

Muzaffarnagar Royal Pustak Bhandar 9761313181

Nanded Debdhar Pustak Bhandar 9423615127

Nasik Rahul Book Center 0253-2599608

Patna Current Book Services 9431077745

Raipur Srishti Medical Book House 9300855027

Reewa Palak Medical Book 9893793577

Tinsukia Sharma Book Stall 9435036146

Vishakhapatnam Andhra Medical Book Centre 9985716032

For ADR Booking Poonam Singhal, Mob.- 09219444474,

Abhay Singhal, Mob:- 09319980483.

Wo

rk M

ore

, Alw

ays S

mile

.

bu iQwM~l dks tYn viuh MkbV ls djsa ckgjgsYFk ds fy, gksrs gSa uqdlkunk;d

dbZ ,sls iQwM~l gksrs gSa tks okLro esa vugsYnh gksrs gSa] ysfdu yksx mUgsa gsYnh le>dj [kkrs gSa- bu iQwM~l ds ckjs esa vkidkslgh tkudkjh gksuh pkfg,- gsYnh jgus ds fy, gsYnh [kkuk csgn t:jh gksrk gS- vkt ds le; esa yksxks dh ykbiQLVkbydks iQkWyks djus ls Mk;fcVht] gkVZ Mhftt] gkbZ CyM izs'kj] fLdu leL;k tSlh vkSj Hkh dbZ chekfj;ksa dk lkeuk djuk iM+ldrk gS- yksx dqN ,sls iQwM~l Hkh [kkrs gSa tks gksrk vugsYnh gS ysfdu tkudkjh uk gksus ds dkj.k yksx mls gsYnh ekuysrs gSa- ;fn vkidks vius gsYFk dh ijokg gS rks vkidks vius [kku&iku dk [kkl è;ku j[kus dh t:jr gS- mu iQwM~lds ckjs esa tks fn[krs gsYnh gSa ysfdu gksrs vugsYnh gSa- l liQsn cszM%& vf/dka'k def'k;y czsM vLokLF;dj gksrs gS ;fnmUgsa cM+h ek=kk esa [kk;k tkrk gS] D;ksafd os ifj"d`r xsgw¡ ls cus gksrs gSa] tks iQkbcj vkSj vko';d iks"kd rRoksa esa de gksrsgSa vkSj CyM 'kqxj esa rsth ls o`f} dj ldrs gSa- l vf/dka'k iQyksa dk jl%& iQyksa dk jl vDlj LoLFk ekuk tkrkgS- tcfd jl esa dqN ,aVhvkWDlhMsaV vkSj foVkfeu lh gksrs gSa- ysfdu lkFk gh ;g mPp ek=kk esa rjy phuh Hkh daVsudjrk gS- okLro esa] iQyksa dk jl dksd ;k isIlh tSls 'kdZjk okys is; ds :i esa cl phuh ds :i esa gksrk gS vkSjdHkh &dHkh blls Hkh vf/d- l uk'rs esa ehBk vukt%& uk'rk esa vukt tSls fd xsg¡w] tbZ] pkoy vkSj edbZ lalkf/krgksrs gSa- os fo'ks"k :i ls cPpksa ds chp yksd-fiz; gksrs gSa vkSj vDlj nw/ ds lkFk [kk, tkrsgSa- vDlj yksx bls Lokfn"V cukus ds fy,phuh 'kkfey djrs gS- dqN brus ehBs gksrs gSafd mudh rqyuk dSaMh ls Hkh dh tk ldrh gS-yksxksa dks yxrk gS fd ;g gsYnh gS ysfdu,slk okLro esa ;g vkids CyM 'kqxj dksc<+krk gS ;g fiQj eksVkis esa Hkh o`f} djrkgS- l yks&iQSV ;ksxVZ%& ngh vfo'oluh; :ils LoLFk gks ldrk gS- ysfdu nqdkuksa esa feyusokys ngh gsYnh ds fy, [kjkc gksrs gSa- os iQSV esavDlj de gksrs gSa] ysfdu iQSV dksdEiUlsV djus ds fy, mlesa phuh 'kkfeyfd;k tkrk gS- lh/s 'kCnksa esa dgasa] vf/dka'kngh esa ,d vLokLF;dj ?kVd dslkFk izfrLFkkfir LoLFk] izkd`frd olk gksrk gS-blds vfrfjDr] dbZ ;ksxVZ izksck;ksfVdcSDVhfj;k iznku ugha djrsa gSa tSlk fdvkerkSj ij ekuk tkrk gS- os vDljikLpqjhd`r gksrs gSa] tks muds vf/dka'kthok.kqvksa dks ekjrk gSa- l lykn%& fliQZblfy, fd lykn gS rks og gsYnh gh ,slk fcYdqy Hkh t:jh ugha gS- jsLrjka esa feyus okys lykn vkerkSj ij vugsYnhgksrs gSa D;ksafd muesa cgqr lh phtsa feyh gqbZ gksrh gSa- iusjk czsM vkSj dsy lykn esa 600 dSyksjh vkSj 40 xzke phuhgksrh gS] tks fd ik¡p yksxksa dh fyfVy phtcxZj ls vf/d gS-

3 o"kZ rd ?kj cSBs ;g lekpkj i=k i<+us ds fy;s gekjs iatkc uS'kuy cSad] cqyUn'kgj ds tks fd iQkekZ niZ.k [kkrk la[;k 1824002100118703] IFSC Code - PUNB0182400 Branch- Deputy Ganj ds uke ls gS] esa :ú 250@& tek dj viuk iwjk irk gekjs iQksu uaú& 09410434811 ij SMS dj nsa-

ww

w.m

ed

icald

arp

an

.co

m

{kf.kdkfu'p;

dfBu dke] vklku gks tk,-;fn eu esa] n`<+rk vk ik,-

ekuleu ls gkjs] lc dqN gkjs-eu ls thrs] lc dqN thrs-

rjhdkvkalw fxjk dj] xe nwj dj ikvks-fiQj psgjs ij] galh dks ys vkvks-

:ikUrj.kmYyw dHkh Hkh mYyw dks]

mYyw ugha cukrk-dsoy balku gh balku]

dks mYyw cukrk-

pkgrekuo cu] ikuk gS-

ekuork dks] txkuk gS-

ifjgklgkL; rks thou esa] pkfg,-vkf[kj dc rd] jksrs tkbZ,-

y{;,d fn'kk esa] pyrs tkbZ,-liQyrk dks] vo'; ikbZ,-

rF;vkbZuk dHkh Hkh] >wB ugha

fn[kkrk-c<+rh vk;q dks] dHkh u dHkh

crkrk-

R;kSgkj[kqf'k;k¡ eukvks] xys yx tkvks-erHksn Hkqykdj] izxfr iFk ij

vkvks-

nhiksRlo,sls nhi] fey dj tyk,a-tks rwiQkuksa esa] cq> u ik,a-

lkspjksxh lgh gqvk]

rks izHkq dh okgokgh-jksxh ej x;k]

rks MkWDVj dh ykijokgh-&MkWñ ujsUnz ukFk ykgk] Xokfy;j(eñizñ)] eksñ 09753698240-

Lej.kh; fnol3 uoEcj & xq: xksfoUn flag 'kghn fnol-4 uoEcj & olqnso cyoUr iQM+ds t;arh (1845bZñ)-5 uoEcj & lezkV gsepUnz (foØekfnR; dk cfynku fnol) (1556bZñ)7 uoEcj & egku~ oSKkfud pUnz'ks[kj oSaDVjeu dk tUe (1888bZñ-)7 uoEcj & fofiu pUnz iky t;Urh-10 uoEcj & f'kokth }kjk viQty [kk¡ dk o/ (1659bZñ)]

ekñ ek/ojko eqys t;arh (1912bZñ)-10 uoEcj & Jh xq:xksfoUn flag cfynku fnol (1708bZñ-)14 uoEcj & dkfrZd iwf.kZek Luku- xq:ukud t;Urh15 uoEcj & fcjlk eqaMk t;Urh (1875bZñ)18 uoEcj & ek/o jko is'kok dk fu/u (1772bZñ)-19 uoEcj & ekñ ,dukFk jkukMs t;arh (1924bZñ)]

ekñ HkkÅjko nsojl t;Urh (1917bZñ)-19 uoEcj & xq: rsxcgknqj] HkkbZ efrnkl] HkkbZ lfrnkl]

HkkbZ n;kynkl cfynku fnol (1675bZñ)-30 uoEcj & oSKkfud txnh'k pUnz clq dk tUefnu (1858bZñ)-

Back Pain vkSj balksefu;k ds bykt esa nokvksa ls vf/d dkjxj ;ksxkfiNys fnuksa gqbZ ,d LVMh esa crk;k x;k Fkk fd ØkWfud cSd isu ls ijs'kku 59 ijlsaV ejhtksa dks vfuæk dh leL;kHkh gksrh gS- dbZ jksxh rks bl nkSjku bUlksefu;k fMlvkWMZj ls ihfM+r gks tkrs gSa- ;ksx ds çHkko dks vc iwjh nqfu;kLohdkjus yxh gS-,d ckj fiQj 'kks/drkZvksa us ;ksx ds çHkko dks ekWMZu fMtht esa ennxkj ekuk gS- ;g 'kks/ vesfjdkesa fd;k x;k] ftlesa lkeus vk;k fd yksvj cSd vkSj uhan u vkus dh leL;k ls tw> jgs yksxksa ds fy, ;ksx djukcgqr gh iQk;nsean jgrk gS-cksLVu eSMhdy lsaVj }kjk cSd isu ds bykt ds fy, ;ksx vkSj lkbdksFksjsih ds çHkko ls tqM+hfjlpZ dh xbZ- gky gh bl fjlpZ dk çdk'ku tuZy vkWiQ tujy baVjuy esfMlUl esa fd;k x;k- fjlpZ esa crk;k x;kfd Lyhi fMlvkWMZj vkSj cSd isu ds bykt esa lkbdksFksjsih vkSj ;ksx csgn enn~xkj gks ldrs gSa- buds çHkko ds pyrsejhtksa dks cgqr gh de ek=kk esa isu fdylZ dh t:jr gksrh gS- fiNys fnuksa gqbZ ,d LVMh esa crk;k x;k Fkk fd ØkWfudcSd isu ls ijs'kku 59 ijlsaV ejhtksa dks vfuæk dh leL;k Hkh gksrh gS- dbZ jksxh rks bl nkSjku bUlksefu;k fMlvkWMZjls ihfM+r gks tkrs gSa- gkykafd bUlksefu;k vkSj cSd isu nksuksa ds fy, gh i;kZIr vkSj mfpr nokb;k¡ miyC/ gSa-ysfdubuds vf/d vkSj yacs le; rd lsou ls jksfx;ksa esa bu nokb;ksa ds lkbM biQsDV~l gksus yxrs gSa- bu lkbM biQsDV~l lscpus dk lcls lgh] lVhd vkSj vklku mik; gS fd fdlh Vªsuj dh ns•js• esa jksfx;ksa dks ;ksx djk;k tk,- blls ukdsoy jksfx;ksa dks nnZ vkSj vfuæk ls NqVdkjk feysxk cfYd os nokb;ksa ds lkbM biQsDV~l ls Hkh cps jgsaxs-

Never B

reak G

oo

d R

ela

tion

fudq¡t Lokeh dh vksj ls czts'k dqekj xxZ }kjk izdkf'kr] czts'k dqekj xxZ }kjk eqfær rFkk bEizzs'kal fizafVax ,.M iSfdax fyfefVM uks,Mk] xkSre cq¼ uxj esa eqfær ,oa ch0,u0 eSMhdy dkWEIySDl] cqyUn'kgj ls izdkf'kr lEiknd& czts'k dqekj xxZ

dSfeLVksa dh leL;k;sa lekIr gksxhadSfeLVksa ds lek/ku gsrq iatkc ljdkjLokLF; ea=kh rFkk fçafliy lsDVjh iatkcljdkj o LokLF; foHkkx iatkc ljdkjiQwM ,aM Mªx ,MfefuLVªs'ku rFkk iatkcdSfeLV ,lksfl,'ku dh ,d ehfVax 18-10-2019 dks lqcg ifjokj dY;k.k HkoufLFkr lsDVj& 34 paMhx<+ esa cqykbZ- iatkcdSfeLV ,lksfl,'ku }kjk iatkc ljdkjLokLF; ea=kh o iatkc ljdkj dks viuhvk jgh leL;kvksa ls voxr djok;k Fkk-mlds ckn iatkc ds eq[;ea=kh us LokLF;ea=kh dks iatkc dSfeLV ,lksfl,'ku }kjk

Hksts x, i=k dk gokyk nsrs gq, mudh ekaxksa ij fopkj djus dks dgk Fkk- ftl ij LokLF;ea=kh us dSfeLV ,lksfl,'ku ds inkf/dkfj;ksa dks paMhx<+ fLFkr cqyok;k Fkk] rFkk mudhekaxksa dk i=k ysdj dgk Fkk fd dqN dkj.kksa ds o'k rFkk R;kSgkjksa ds eísutj mlds ckn,d ehfVax djus dks dgk Fkk- ftldks ysdj vc LokLF; foHkkx dk ,d i=k tks iatkcdSfeLV ,lksfl,'ku ds uke tkjh gq, gSa- mudks dSfeLV ,lksfl,'ku ds çfrfuf/eaMy (iatkcdSfeLV ,lksfl,'ku ds ç/ku Jh lqjsaæ nqXxy] tujy lsDVjh th,l pkoyk] Treasurervejnhi flag miQZ nhi] rFkk vkSj dbZ ftyksa ds vè;{k vkSj lfpo lfgr paMhx<+ fLFkrehfVax ds fy, cqyk;k x;k gS] vkSj yxrk gS fd tgk¡ rd laHko gks ldrk gS] ljdkjdSfeLVksa ds fgr ds fy, dkiQh dqN ekaxksa dks Lohdkj djsxh- og Hkh iatkc dSfeLV,lksfl,'ku ds ncko dks ns•rs gq,- xkSj gks fd iatkc dSfeLV ,lksfl,'ku us ,d fnu dkiatkc can dk Hkh vkÞoku fd;k Fkk- ftldks ysdj iatkc ljdkj ldrs esa vk xbZ Fkh] vkSjdSfeLV ,lksfl,'ku dks can uk djus dks ysdj gokyk fn;k Fkk] vkSj mudh ekaxksa ij fopkjdjus dks dgk Fkk- ftldk urhtk ;g gqvk fd iatkc ljdkj us iatkc dSfeLV ,lksfl,'kuds ç/ku Jh lqjsaæ nqXxy dks ,d i=k Hkstdj can dh dky dks #dokus] dFkk mudh ekaxksaij fopkj djus dks ysdj i=k Hkh fy•k Fkk- &galjkt esgrk eksñ 09814132529-

ZYDUS RECEIVES FINAL APPROVAL FROM THE USFDA FOR CISATRACURIUM BESYLATE INJECTION USP

Ahmedabad, 5 November, 2019:- Zydus Cadila Mob:- 09368696718, 09410210556,

09359503863, 09329621787, 09368010386 has received the final approval from theUSFDA to market Cisatracurium Besylate Injection USP 10 mg (base)/5 mL (2 mg/mL)and 200 mg (base)/20 mL (10 mg/mL) Single-Dose Vials (Preservative-free) (US RLD-Nimbex). This medication is used to relax the muscles. It works by blocking the signalsbetween one’s nerves and one’s muscles. This medicine is given before general anaes-

thesia in preparing for surgery. It will be manufactured at Liva Pharmaceuticals Limited, a wholly-owned subsidiarycompany of Cadila Healthcare Limited. The group now has 275 approvals and has so far filed over 360 ANDAssince the commencement of the filing process in FY 2003-04.

fgekpy esa 13 nokvksa ds lSaiy iQsy] Mªx vyVZ tkjhlksyu] 13 uoEcj (iky)% fgekpy esa cu jgh 13 nokvksa ds lSaiy iQsy gks x, gSa- fiNys10 eghuksa esa fu/kZfjr ekudksa ij iQsy gqbZ nokvksa dh la[;k c<+dj 90 gks xbZ gSa- dsanzh;nok ekud fu;a=kd laxBu (lh-Mh-,l-lh-vks-) us bl ekg dk Mªx vyVZ tkjh fd;k gS-blesa ns'k Hkj esa 36 nokvksa ds lSaiy gq, gSa- lh-Mh-,l-lh-vks- us ns'k Hkj esa 1163 nokvksads lSaiy dh tk¡p dh ftlesa 36 nokvksa ds lSaiy gq, gSa- buesa ls 13 nokvksa dk mRiknufgekpy esa gks jgk gSa- izns'k esa lcls vf/d ch-ch-,u- vkS|ksfxd {ks=k dh 9 nokvksa dslSaiy gq, gSa tcfd ftyk dkaxM+k ds lalkj ij VSjsl ds 2 ftyk mQuk ds gjksyh o ftykfljekSj ds dkykvac m|ksx dk 1&1 lSaiy iQsy gqvk gS- ftu nokvksa ds lSaiy gq, muesagkVZ] ch-ih- 'kqxj cq[kkj] ,aVhck;ksfVd dSfY'k;e ,ythZ bR;kfn dh nokvksa ds lSaiy 'kkfeygSa- Mªx foHkkx us mu lHkh m|ksxksa dks cktkj ls mu nokvksa ds cSap ds LVkWd fjdkWy djusds funsZ'k tkjh dj fn, gSa ftuds lSaiy iQsy gq, gSa- lh-Mh-,l-lh-vks- ls feyh tkudkjhds vuqlkj guqpSe yScksjsVjht ekuiqjk cíh dh ,ftFkksjsfeflu vksjy lLisa'ku 100 ,e-th- dkcSp uacj&,y&1724703] ckW;kstSfufVd Mªx >kM+ektjh dh ,yizksiQsu~ VScysV 400 ,e-th- dkcSp 01019 oh-ts-,- 36] ikdZ iQkekZL;wfVdy dkyqf>aMk utnhd ukudiqj cíh dhekWfDliQykWfDlu vkbZMªWki dk cSp ,y-,p-,y-& 2692] viklekbZ vksdqyj fMokbl dkBkcíh dh Vks;ksVª vkbZ 5 ,l-,y- dk cSp&bZ-Vh-ch- 045] D;ksjVSd fLdu ds;j HkVksyhdykaHkqMM~ dh cSVkfeFkeu fMizksfiz;ksfuV Øhe dk cSp vkj-Mh- 459] th-,u-ch- eSMhdkyScukykx<+ dh (vkbZ-,y-,-oh-bZ&625 VSDysV ) dk cSp &Vh-th- 19&32]th-,e-ch- eSMhdkyScukykx<+ dh flfiQfDle fMlfizftcy VScysV (,l-,-,e-lh-bZ-,iQ&200 Mh-Vh-) dk cSp &Vh-,iQ] 19&88] vycSu gSYFk ds;j dkykvac fljekSj dh yqtksy dk cSp 393] foaXt ck;ksVSdcíh dh dSfY'k;e dkcksZusV VScysV dk cSp & lh-ch-vkj-Vh- 1041] th-,u-ch- eSMhdkyScukykx<+ dh (vuqeksDl&lh-oh-&,y-ch- VScysV ) dk cSp & Vh-th- 19&36 VhVkuSl iQkekZgjksyh mQuk dh esViQksjekbu gkbZMªksDyksjkbM VScysV dk cSp & ,e] 500 ,l-vkj-Vh- 1901]ds;jeSDl iWQkewZys'ku lalkjiqj VSjsl dkaxM+k dh (,fedkds;j 500) dk cSp &lh-,y-vkbZ-]6868 o VSjsl iQkekZL;wfVdy dkaxM+k dh jSeksfizy VScysV dk cSp &,l-Vh-,u- 181394,-dk lSaiy iQsy gks x;k gSa- &galjkt esgrk th] eksñ 9814132529-

Indoco’s Clinical Research Organisation Receives Zero 483s From USFDA

Mumbai:- Indoco Remedies Ltd. Mob:- 09758502980, 09999113560, 07895573946,

07417285763, 09412283241 announced today, that its Clinical Research Organisation,AnaCipher, located at Hyderabad successfully cleared the United States Food and DrugAdministration (USFDA) inspection with zero 483s. The inspection was held from 14thOctober to 18th October, 2019. Commenting on this development, Ms. Aditi KarePanandikar, Managing Director, Indoco Remedies Limited said, “This achievement is for

the fifth time in a row and confirms the capabilities of our team at the CRO for maintaining highest quality stan-dards and excellence in servicing our clients”. The CRO - AnaCipher conducts Bio-Equivalence and Bio-Availability (BA/BE) studies at its facility in Hyderabad and is spread over an area of 30,000 sq. ft. with 98 beds.

Dr. Reddy's Laboratories Announces Launch Of DoxercalciferolInjection In The U.S. Market

Hyderabad:- Dr. Reddy’s Laboratories Ltd. Mob:- 09368696718,

09410210556, 09359503863, 09329621787, 09368010386 along with its sub-sidiaries together referred to as “Dr. Reddy’s”) today announced the launch ofDoxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, the ther-apeutic generic equivalent of Hectorol® (doxercalciferol) Injection 4 mcg/2 mL(2 mcg/mL) MultipleDose Vials, approved by the U.S. Food and DrugAdministration (USFDA). The Hectorol® Injection 4 mcg/2 mL (2 mcg/mL)

Single-Dose Vials and Multiple-Dose Vials brand and generics had U.S. sales of approximately $138 mil-lion MAT for the most recent twelve months ending in September 2019 according to IQVIA Health*.

Sun Pharma And AstraZeneca Enter Into License Agreement For Novel Oncology Products In China

Mumbai:- Sun Pharmaceutical Industries Ltd. Mob:- 09958124414, 09412480312

“Sun Pharma” and includes its subsidiaries and/or associate companies) today

announced that it has entered into a licensing agreement with AstraZeneca UK Ltd.

(AstraZeneca) to introduce certain novel readyto-use (RTU) infusion oncology prod-

ucts in China. The agreement will help to bring costeffective and quality drugs to

patients in China. As per the terms of the agreement, Sun Pharma will be responsible

for development, regulatory filings and manufacturing the products covered in the

agreement while AstraZeneca will exclusively promote and distribute these products in

China. The initial tenure of the agreement is 10 years from the first commercial sale of

the said products in China. The financial terms of the agreement are confidential. Kal Sundaram, Director

of Corporate Development, Sun Pharma said, “We are pleased to partner with AstraZeneca for commer-

cialisation of our select novel oncology products in China. AstraZeneca’s leadership position will help us to

make our products available to patients and doctors in China. We see a great potential to introduce our

speciality and generics products in the growing China market and this licensing agreement is another pos-

itive step in that direction.” The agreement will be announced today at the China International Import Expo

(CIIE) in Shanghai. CIIE is a world-class expo that is organised by Ministry of Commerce of the People's

Republic of China. It is an open cooperation platform to invite countries into China to showcase their

national image and engage in international trade.

Glenmark Pharma Gets USFDA Nod For Diabetes Management DrugNEW DELHI:- Glenmark Pharmaceuticals Mob:- 09999442531, 09319755551

on Tuesday said it has received final nod from the US health regulator for met-formin hydrochloride tablets used in the management of type-two diabetes."Glenmark Pharmaceuticals Inc, USA, has been granted final approval by theUnited States Food & Drug Administration (USFDA) for metformin hydrochlorideextended release tablets USP, 500 mg and 1000 mg, the generic version of

Glumetza extended release tablets, 500 mg and 1,000 mg, of Salix Pharmaceuticals Inc," the drug makersaid in a filing to BSE. Citing IQVIA sales data for the 12-month period ending September 2019, the com-pany said that Glumetza tablets, 500 mg and 1,000 mg market achieved annual sales of approximatelyUSD 226.7 million. Glenmark's current portfolio consists of 164 products authorised for distribution in theUS marketplace and 44 abbreviated new drug applications pending approval with the USFDA.

Mk;fCkVht esa dkSu lk iQy [kk;sa\iQy LokLF; ds fy, dkiQh iQk;nsean gksrs gSa- iQyksa esa foVkfeu] ,aVhvkWDlhMsaV] iQkbcj]feujy] vk;ju vkSj vU; ikS"kd rRo ik, tkrs gSa- ;s iQy c<+k ldrs gSa CyM 'kqxjysoy l Mªkb izQwV%& Mªkb izwQV esa 'kqxj dh ek=kk vf/d gksrh gSa tSls fd'kfe'k] dktwbuesa ikuh dh ek=kk de vkSj 'kqxj dh ek=kk vf/d gksrh gSa- blfy, t:jh gS fd vkiMªkb izwQV dk lsou lhfer ek=kk esa djsa ;g bUgsa vf/d [kkus ls cpsa- l gkbZ dkcZ okysiQy%& rkts iQy [kkus LokLF; ds fy, dkiQh vPNs gksrs gSa ysfdu dqN iQyksa ls nwjjguk LokLF; ds fy, t:jh gSa D;ksafd ;s rqjar CyM 'kqxj ysoy c<+k nsrs gSa- tSls dsys]vke] lsc vf/d ek=kk esa ugha [kkus pkfg, blfy, vius iQyksa dk pquko djrs le;muds vkdkj dk è;ku j[kuk pkfg,- blds lkFk gh t:jh gS fd iQyksa esa dkcZ dh ek=kkij è;ku j[ksa- l iQyksa dk jl%& iQyksa dk jl ejhtks dks fcuk MkDVj ds lykg ds fcukugha ihuk pkfg,- twl esa 'kqxj dh ek=kk vf/d gksrh gSa tks vkids 'kqxj dks c<+k ldrkgSa- blfy, twl dh ctk, yksxksa dks rkts iQy dh lykg nh tkrh gS rkfd CyM 'kqxjdks c<+us ls jksdk tk lds vkSj vf/d ls vf/d ikS"kd rRo 'kjhj esa tk ldsa-